Skip to main content

Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.

Publication ,  Journal Article
Taghipour, M; Mena, E; Kruse, MJ; Sheikhbahaei, S; Subramaniam, RM
Published in: Nucl Med Commun
March 2017

OBJECTIVE: To compare the accuracy of same-day therapy-assessment PET/computed tomography (PET/CT) and conventional contrast-enhanced computed tomography (CECT) in patients with oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A total of 110 (95 men and 15 women; mean age 59 years) patients with biopsy-proven OPSCC were evaluated with same-day PET/CT and CECT pair scans as part of follow-up therapy assessment. Scans were performed within 6 months after the completion of primary treatment (median time: 3.1 months; range: 0.5-6 months). PET/CT and CECT scans were reviewed retrospectively for residual primary site disease, and right and left cervical lymph node involvement. Histopathology or 6 month clinical/imaging follow-up were used as the gold standard. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated for the primary site and cervical nodal disease. RESULTS: Of 110 OPSCC patients, 90.9% were human papilloma virus positive, 80.8% were stage 4, and 76.4% received chemoradiation as the primary treatment. The sensitivity, specificity, PPV, NPV, and accuracy of PET/CT and CECT were similar in the evaluation of the primary cancer site (PET/CT: 75.0, 91.5, 25.0, 99.0, and 90.9, respectively, versus CECT: 75.0, 90.6, 23.1, 99.0, and 90.0, respectively). In evaluating cervical lymph node involvement, PET/CT appeared to have higher accuracy (96.8 vs. 81.7%), specificity (97.7 vs. 81.7%), and PPV (45.8 vs. 16.5%), comparable NPV (99.4% for both), and lower sensitivity (65 vs. 75%) compared with same-day CECT. CONCLUSION: Same-day PET/CT and CECT scans had comparable accuracy in the evaluation of primary tumor sites after completion of therapy in patients with OPSCC. PET/CT showed higher accuracy in the evaluation of cervical lymph node involvement.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nucl Med Commun

DOI

EISSN

1473-5628

Publication Date

March 2017

Volume

38

Issue

3

Start / End Page

250 / 258

Location

England

Related Subject Headings

  • Sensitivity and Specificity
  • Positron Emission Tomography Computed Tomography
  • Oropharyngeal Neoplasms
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Humans
  • Follow-Up Studies
  • Fluorodeoxyglucose F18
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Taghipour, M., Mena, E., Kruse, M. J., Sheikhbahaei, S., & Subramaniam, R. M. (2017). Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study. Nucl Med Commun, 38(3), 250–258. https://doi.org/10.1097/MNM.0000000000000639
Taghipour, Mehdi, Esther Mena, Matthew J. Kruse, Sara Sheikhbahaei, and Rathan M. Subramaniam. “Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.Nucl Med Commun 38, no. 3 (March 2017): 250–58. https://doi.org/10.1097/MNM.0000000000000639.
Taghipour M, Mena E, Kruse MJ, Sheikhbahaei S, Subramaniam RM. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study. Nucl Med Commun. 2017 Mar;38(3):250–8.
Taghipour, Mehdi, et al. “Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.Nucl Med Commun, vol. 38, no. 3, Mar. 2017, pp. 250–58. Pubmed, doi:10.1097/MNM.0000000000000639.
Taghipour M, Mena E, Kruse MJ, Sheikhbahaei S, Subramaniam RM. Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study. Nucl Med Commun. 2017 Mar;38(3):250–258.

Published In

Nucl Med Commun

DOI

EISSN

1473-5628

Publication Date

March 2017

Volume

38

Issue

3

Start / End Page

250 / 258

Location

England

Related Subject Headings

  • Sensitivity and Specificity
  • Positron Emission Tomography Computed Tomography
  • Oropharyngeal Neoplasms
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Humans
  • Follow-Up Studies
  • Fluorodeoxyglucose F18
  • Female